9:00-17:30 If you have any questions, please feel free to ask us
bulk pharmaceutical intermediates

Pharmaceutical Use of 1-3-Dimethylurea

Pharmaceutical Use of 1-3-Dimethylurea

In the intricate world of pharmaceutical synthesis, the quest for high-purity, reliable intermediates is never-ending. Among these crucial building blocks, 1-3-Dimethylurea stands out for its pivotal role in creating life-enhancing medications. This simple yet versatile organic compound, with the molecular formula C3H8N2O, serves as a foundational stone in the production of critical drugs like caffeine and theophylline. Its importance extends beyond its direct applications, as its structural principles inform the development of more complex derivatives, such as 3 3 4 dichlorophenyl 1 1 dimethylurea. For pharmaceutical companies and research institutions globally, securing a consistent supply of high-grade 1-3-Dimethylurea is synonymous with ensuring the integrity, efficiency, and scalability of their synthesis pipelines. This article explores the indispensable pharmaceutical applications of 1-3-Dimethylurea, its relationship to its molecular identity C3H8N2O, and the quality standards that differentiate a superior intermediate.

 

Pharmaceutical Use of 1-3-Dimethylurea

 

The Foundational Role of 1-3-Dimethylurea in API Synthesis 

 

The pharmaceutical use of 1-3-Dimethylurea is primarily anchored in its function as a high-value intermediate in Active Pharmaceutical Ingredient (API) manufacturing. Its chemical structure makes it an ideal precursor in synthesizing xanthine derivatives, most notably caffeine and theophylline. These compounds are not only central nervous system stimulants but also serve as core structures for more complex therapeutic agents. The reliability of the final API is intrinsically linked to the purity and consistency of the 1-3-Dimethylurea used in the reaction sequence. Any impurity in this starting material can propagate through the synthesis, affecting yield, necessitating costly purification steps, and potentially compromising the safety profile of the final drug. Therefore, manufacturers prioritize sourcing 1-3-Dimethylurea produced under strict Good Manufacturing Practice (GMP) conditions, where parameters like the molecular formula C3H8N2O are verified with each batch to ensure chemical fidelity and predictable reactivity.

 

From C3H8N2O to Complex Derivatives: Understanding the Molecular Blueprint 

 

The specific properties enabling the pharmaceutical use of 1-3-Dimethylurea are dictated by its precise molecular architecture, represented by the formula C3H8N2O. This blueprint defines its physical characteristics—such as solubility and melting point—and its chemical reactivity. Understanding this structure is key to appreciating how 1-3-Dimethylurea can be modified to create more specialized compounds. For instance, the knowledge gained from working with this dimethylurea isomer directly informs the synthetic pathways for creating halogenated analogues like 3 3 4 dichlorophenyl 1 1 dimethylurea, which may possess unique biological activities for agrochemical or pharmaceutical research. The ability to reliably produce the simple C3H8N2O structure with high purity is the first, critical step in exploring these advanced chemical spaces, making it a cornerstone for both standard production and innovative research and development.

 

Quality Specifications for Pharmaceutical-Grade 1-3-Dimethylurea 

 

The efficacy of 1-3-Dimethylurea in pharmaceutical synthesis is guaranteed only when it meets exacting quality specifications. These parameters are non-negotiable and must be documented for every batch to ensure compliance with global regulatory standards. The following table outlines the core specifications that define premium, pharmaceutically relevant 1-3-Dimethylurea:

 

Parameter

Detail

Product Name

1,3-Dimethylurea; N,N'-Dimethyl urea

CAS Nha.

96-31-1

Molecular Formula

C3H8N2O

Molecular Weight

88.11

Appearance

Colorless crystalline powder

Purity (Assay)

≥ 99.0% (by HPLC)

Moisture Content

≤ 0.5% (by KF)

Related Substances

Controlled to ICH guidelines

 

Adherence to these specifications, particularly the high assay purity and controlled moisture, is what distinguishes a material suitable for the pharmaceutical use of 1-3-Dimethylurea from a technical-grade product. This level of quality ensures optimal reaction yields, prevents side reactions, and supports the stringent documentation required for Drug Master Files (DMFs), thereby streamlining the regulatory approval process for the final API.

 

1-3-Dimethylurea in Research: Beyond Caffeine and Theophylline --H2 While its role in producing caffeine and theophylline is well-established, the pharmaceutical use of 1-3-Dimethylurea continues to expand in research domains. Its utility as a building block in crystal engineering and medicinal chemistry is significant. Researchers value 1-3-Dimethylurea for its ability to form hydrogen bonds and its well-understood reactivity, making it a model compound for studying molecular interactions. Furthermore, the structural knowledge derived from C3H8N2O is applied in designing and synthesizing novel compounds, including specialized derivatives like 3 3 4 dichlorophenyl 1 1 dimethylurea for targeted biological screening. This expanding scope underscores the importance of sourcing 1-3-Dimethylurea from suppliers who understand its scientific context and can provide consistent material that supports both large-scale manufacturing and cutting-edge exploratory synthesis.

 

About Pharmaceutical Use of 1-3-Dimethylurea Key Advantages FAQs 

 

To clarify its value proposition, here are answers to common questions about the advantages of high-quality 1-3-Dimethylurea.

 

What defines pharmaceutical-grade 1-3-Dimethylurea? 

 

Pharmaceutical-grade 1-3-Dimethylureais defined by high purity (≥99%), strict control of impurities and moisture, and production under a quality management system aligned with GMP principles. This ensures the C3H8N2O compound performs predictably in sensitive synthesis, guaranteeing the safety and efficacy of the final drug product.

 

Why is C3H8N2O purity critical for synthesis? 

 

The purity of the C3H8N2O molecule is critical because impurities can act as catalysts for unwanted side reactions, reduce the yield of the target API (like caffeine), and introduce contaminants that are difficult and expensive to remove in later stages. High-purity 1-3-Dimethylurea ensures efficient, scalable, and cost-effective manufacturing.

 

How does 1-3-Dimethylurea support complex derivative synthesis? 

 

1-3-Dimethylurea serves as a foundational scaffold. Its well-characterized reactions provide a reliable starting point for synthesizing more complex molecules, such as 3 3 4 dichlorophenyl 1 1 dimethylurea. Consistent quality in the starting material is essential for reproducing and optimizing these advanced synthetic pathways in research.

 

Can you supply 1-3-Dimethylurea for global pharmaceutical projects? 

 

Yes, we supply 1-3-Dimethylurea that meets international pharmacopoeial standards, supported by full regulatory documentation including Certificates of Analysis (CoA) and stability data. Our logistics network ensures reliable delivery to pharmaceutical and research facilities worldwide.

 

What is your quality assurance for 1-3-Dimethylurea? 

 

Our quality assurance for 1-3-Dimethylurea includes batch-specific testing against stringent specifications (like those in the table above), production in audited facilities, and full traceability. We ensure every kilogram of C3H8N2O conforms to the requirements for sensitive pharmaceutical use.

 

The pharmaceutical use of 1-3-Dimethylurea is a testament to how a precisely engineered simple molecule can underpin complex and vital healthcare innovations. From its direct role in API manufacturing to its value in advanced research for compounds like 3 3 4 dichlorophenyl 1 1 dimethylurea, its importance is undeniable. Success in these applications hinges on an unwavering commitment to quality at the C3H8N2O level.

 

Partner with a cornerstone manufacturer in fine chemical synthesis. When you choose Shijiazhuang Kunxiangda Technology Co., Ltd., you align with an enterprise built on over a decade of specialization in high-purity pharmaceutical intermediates like 1-3-Dimethylurea. Our 50-acre, advanced production facility, staffed by over 300 professionals including 9 technical experts, operates under a philosophy where quality is paramount. Through strategic collaborations with institutions like Tsinghua University, we continuously refine our processes to ensure technical leadership and cost-effective, reliable supply. Our established global network, delivering to dozens of countries, stands as a testament to our commitment to being the most trusted partner for our customers. For a supply chain defined by integrity, harmony, and unwavering quality, contact Kunxiangda today. Let us provide the high-purity C3H8N2O that underpins your critical pharmaceutical innovations.

More product recommendations

Kana iwe uchifarira zvigadzirwa zvedu, unogona kusarudza kusiya ruzivo rwako pano, uye isu tichabatana newe munguva pfupi.


Need Help?
Drop us a message using the form below.